UT Southwestern spinout Recode Therapeutics has completed an oversubscribed $80m series A round featuring Osage University Partners.
Illumina was among the returning investors for the round that will help Columbia spinout Kallyope prepare a weight loss treatment for clinical trials.
Duke University, North Carolina State University and UNC-Chapel Hill grew their cumulative spinout tally year-on-year but are set for challenging times ahead.
The Montana State University-backed edible protein developer has rebranded from Sustainable Bioproducts and received series B funding.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Dragonfly, whose co-founders include MIT and UC Berkeley faculty, has boosted its total financing to $300m in round of undisclosed size led by Fidelity.
University of Wisconsin-Madison gene medicine developer Design Therapeutics has attracted SR One for its series A round.
UC Berkeley's Nurix Therapeutics will use the capital to prepare two protein modulation-based immuno-oncology drugs for the clinic.